PPWD1 is a peptidylprolyl isomerase containing WD40 repeats that catalyzes cis-trans isomerization of proline imidic peptide bonds, potentially assisting protein folding 1. As a nuclear cyclophilin, PPWD1 functions as a 'spliceophilin' involved in pre-mRNA splicing within spliceosomal complexes 23. The protein contains both an isomerase catalytic domain and WD40 repeats, with structural studies revealing a pseudo-substrate immediately N-terminal to the cyclophilin domain that may facilitate spliceosomal function 3. In disease contexts, PPWD1 expression is dysregulated across multiple cancer types. PPWD1 functions as a tumor suppressor in cervical carcinoma, where its expression is regulated by the lncRNA RP11-284F21.9 through miR-769-3p competitive binding 4. In lung adenocarcinoma, miR-629-5p directly targets PPWD1 to promote tumor invasion and metastasis 5. PPWD1 serves as a molecular marker: it differentiates pancreatic from ileal neuroendocrine tumor primaries with 80% sensitivity 6 and associates with bicalutamide resistance in prostate cancer through RNA splicing pathways 7. Additionally, PPWD1 expression correlates with bone mineral density and represents a potential biomarker for postmenopausal osteoporosis diagnosis 8.